Adding ipilimumab to standard chemotherapy treatment for late-stage lung cancer may improve survival
Thursday, December 9, 2010 - 10:01
in Health & Medicine
-- Ipilimumab used in combination with paclitaxel/carboplatin for stage IIIb/IV non-small cell lung cancer showed superior results in progression free survival when compared to paclitaxel/carboplatin...
